FDA Approves Balloon Device for Eustachian Tube Dysfunction

Share this content:
FDA Approves Balloon Device for Eustachian Tube Dysfunction
FDA Approves Balloon Device for Eustachian Tube Dysfunction

FRIDAY, Sept. 16, 2016 (HealthDay News) -- A device that uses a small balloon to treat Eustachian tube dysfunction has been approved by the U.S. Food and Drug Administration.

The Aera Eustachian Tube Balloon Dilation System enables doctors to insert a catheter through the nose into the Eustachian tube, where a small balloon is inflated and creates a path for mucus and air. The balloon is then deflated and removed.

In clinical trials, 52 percent of participants given the device had normal Eustachian tube test results six weeks after the procedure, compared with 14 percent who were treated with a conventional nasal spray. The most common side effects included Eustachian tube puncture, minor bleeding, and worsening Eustachian tube dysfunction.

The device shouldn't be used by patients under age 22, among those whose Eustachian tube is always open, or among patients in whom the carotid artery protrudes through a gap in the bone that surrounds the Eustachian tube.

The device is produced by Irvine, Calif.-based Acclarent Inc.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Improved achievement of glycemic targets, reduced body weight

European, American Guidelines Lead to Different Recs for Statins

European, American Guidelines Lead to Different Recs for ...

Quantification of CAC score can improve stratification for those at high, low risk for events

Hyperbaric O2 Therapy Effective in Maxillary Osteoradionecrosis

Hyperbaric O<sub>2</sub> Therapy Effective in Maxillary Osteoradionecrosis

Positive clinical outcome with HBOT for 85.7 percent of patients with maxillary bone osteoradionecrosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »